The mutational burden of acral melanoma revealed by whole-genome sequencing and comparative analysis-Reference-Cited by-同舟云学术

The mutational burden of acral melanoma revealed by whole-genome sequencing and comparative analysis

Published:2014-06-30 Issue:5 Volume:27 Page:835-838
ISSN:1755-1471
Container-title:Pigment Cell & Melanoma Research
language:en
Short-container-title:Pigment Cell Melanoma Res.

Author:

Furney Simon J.¹,Turajlic Samra²,Stamp Gordon³,Thomas J. Meirion⁴,Hayes Andrew⁴,Strauss Dirk⁴,Gavrielides Mike¹,Xing Wei⁵,Gore Martin⁶,Larkin James⁶,Marais Richard¹

Affiliation:

1. Molecular Oncology Group; Cancer Research UK Manchester Institute; Manchester UK

2. Signal Transduction Team; Division of Cancer Biology; Institute of Cancer Research; London UK

3. Experimental Pathology Laboratory; Cancer Research UK; London Research Institute; London UK

4. Department of Surgery; Royal Marsden Hospital; London UK

5. Scientific Computing; Cancer Research UK Manchester Institute; Manchester UK

6. Melanoma Unit; Royal Marsden Hospital; London UK

Funder

Cancer Research UK

Harry J. Lloyd Charitable Trust

Rosetrees Trust

Publisher

Wiley

Subject

Dermatology,General Biochemistry, Genetics and Molecular Biology,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/pcmr.12279/fullpdf

Reference20 articles.

1. Signatures of mutational processes in human cancer;Alexandrov;Nature,2013

2. Melanoma genome sequencing reveals frequent PREX2 mutations;Berger;Nature,2012

3. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia;Cancer Genome Atlas Research Network;N. Engl. J. Med.,2013

4. Emerging landscape of oncogenic signatures across human cancers;Ciriello;Nat. Genet.,2013

5. Distinct sets of genetic alterations in melanoma;Curtin;N. Engl. J. Med.,2005

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor-infiltrating lymphocytes and immune-related adverse events in advanced melanoma;Immuno-Oncology and Technology;2024-12

2. Clinicopathological features, response patterns, outcomes and BRAF status in patients with advanced acral melanoma: a preliminary Peruvian study;ecancermedicalscience;2024-08-27

3. Expanding the landscape of oncogenic drivers and treatment options in acral and mucosal melanomas by targeted genomic profiling;International Journal of Cancer;2024-07-12

4. Clinical Characteristics and Special Considerations in the Management of Rare Melanoma Subtypes;Cancers;2024-06-28

5. Adjuvant treatment with anti‐PD‐1 in acral melanoma: A nationwide study;International Journal of Cancer;2024-06-24